Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Glioma 20Glioblastoma 15Brain Neoplasms 11Neuroblastoma 4Neoplasms 4Astrocytoma 4Sarcoma 3Prostatic Neoplasms 2Neurofibromatosis 1 2Neoplastic Cells, Circulating 2Meningioma 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Radiation Injuries 1Polycystic Kidney, Autosomal Recessive 1Pituitary Neoplasms 1Pheochromocytoma 1Parkinsonian Disorders 1Paraganglioma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neurofibromatosis-Noonan syndrome 1Neurofibromatoses 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Proton Therapy 2pegvisomant 1lutetium Lu 177 dotatate 1entinostat 1Temozolomide 1Surveys and Questionnaires 1Rosiglitazone 1Radiation Dose Hypofractionation 1Protons 1Prednisone 1Photochemotherapy 1Octreotide 1Neuropsychological Tests 1Microarray Analysis 1Hydrocortisone 1Dihematoporphyrin Ether 1Dexamethasone 1DNA Methylation 1Clinical Laboratory Techniques 1Calcium Dobesilate 1Cabergoline 1Blood Specimen Collection 1Aminolevulinic Acid 190Y-octreotide, DOTA-Tyr(3)- 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Blood Specimen Collection × CNS × Clear all
NCT03465618 2026-05-01

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
17 enrolled
CNSEndocrine

Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡